Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwNHL 2017 | Exciting advances in checkpoint inhibitors, CAR T-cells and ALK inhibitors

Steven Rosen, MD, from the City of Hope, Duarte, CA, discusses highlights of the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. More concrete data had been released for various novel treatments, such as checkpoint inhibitors, CAR T-cell therapies, and ALK inhibitors. Dr Rosen explains that this is a promising and rapidly evolving field, but there are still many challenges ahead.